Evidence map›Paper›PMID 28855397›Full record

ArticleScience translational medicine2017

Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.

Melissa E Schechter, Bruno B Andrade, Tianyu He, George Haret Richter, Kevin W Tosh, Benjamin B Policicchio, Amrit Singh, Kevin D Raehtz, Virginia Sheikh, Dongying Ma and 8 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Computational Modeling of Pro-inflammatory Cytokine-Enhanced Blood Coagulation.Computational and structural biotechnology journal · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Mutual regulation of CD4Haematologica · 2024
    Article
  14. Review
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Cardiovascular Disease and Thrombosis in HIV Infection.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Melissa E SchechterClinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.ORCID http://orcid.org/0000-0003-3224-7529
Bruno B AndradeImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. bruno.andrade@bahia.fiocruz.br isereti@niaid.nih.gov pandrea@pitt.edu.ORCID http://orcid.org/0000-0001-6833-3811
Tianyu HeCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID http://orcid.org/0000-0002-9427-6694
George Haret RichterCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Kevin W ToshImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID http://orcid.org/0000-0001-6236-8060
Benjamin B PolicicchioCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID http://orcid.org/0000-0002-5423-0819
Amrit SinghHIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID http://orcid.org/0000-0003-0566-3607
Kevin D RaehtzCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Virginia SheikhHIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID http://orcid.org/0000-0003-2006-7440
Dongying MaLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Egidio Brocca-CofanoCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID http://orcid.org/0000-0002-2355-9697
Cristian ApetreiCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID http://orcid.org/0000-0002-0322-7185
Russel TracyDepartment of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine University of Vermont, Burlington, VT 05405, USA.ORCID http://orcid.org/0000-0002-0080-2420
Ruy M RibeiroTheoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87544, USA.ORCID http://orcid.org/0000-0002-3988-8241
Alan SherImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID http://orcid.org/0000-0001-7053-2895
Ivo M B FrancischettiLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID http://orcid.org/0000-0002-5764-5454
Ivona PandreaCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. bruno.andrade@bahia.fiocruz.br isereti@niaid.nih.gov pandrea@pitt.edu.
Irini SeretiHIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. bruno.andrade@bahia.fiocruz.br isereti@niaid.nih.gov pandrea@pitt.edu.ORCID http://orcid.org/0000-0002-0076-0224
University of Pittsburgh · USNational Institutes of Health · USNational Institute of Allergy and Infectious Diseases · USLeidos (United States) · USLos Alamos National Laboratory · USUniversity of Vermont · US

Funding

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) DiseaseZIAAI001121 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SERETI, IRINI · 2010 to 2025
$27.2M
SIV Pathogenesis in African Green Monkeys and Pigtailed MacaquesR01HL117715 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2012 to 2021
$7.0M
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPsR01HL123096 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2015 to 2025
$6.8M
Animal Model for Testing SIV Latency Reversal StrategiesR01AI119346 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2015 to 2019
$3.4M
PITT AIDS RESEARCH TRAINING PROGRAMT32AI065380 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BARRATT-BOYES, SIMON M · 2005 to 2020
$3.2M
Quantifying Immune VS. Viral Killing of SIV Infected and Latently Infected CellsR01AI104373 · NIAID · LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB · PI RIBEIRO, RUY M · 2013 to 2016
$2.7M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENHLBI NIH HHS R01 HL117715NHLBI NIH HHS R01 HL123096NIAID NIH HHS R01 AI104373NIAID NIH HHS R01 AI119346NIAID NIH HHS T32 AI065380
6 · The paper itself

Abstract

In HIV infection, persistent inflammation despite effective antiretroviral therapy is linked to increased risk of noninfectious chronic complications such as cardiovascular and thromboembolic disease. A better understanding of inflammatory and coagulation pathways in HIV infection is needed to optimize clinical care. Markers of monocyte activation and coagulation independently predict morbidity and mortality associated with non-AIDS events. We identified a specific subset of monocytes that express tissue factor (TF), persist after virological suppression, and trigger the coagulation cascade by activating factor X. This subset of monocytes expressing TF had a distinct gene signature with up-regulated innate immune markers and evidence of robust production of multiple proinflammatory cytokines, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and IL-6, ex vivo and in vitro upon lipopolysaccharide stimulation. We validated our findings in a nonhuman primate model, showing that TF-expressing inflammatory monocytes were associated with simian immunodeficiency virus (SIV)-related coagulopathy in the progressive [pigtail macaques (PTMs)] but not in the nonpathogenic (African green monkeys) SIV infection model. Last, Ixolaris, an anticoagulant that inhibits the TF pathway, was tested and potently blocked functional TF activity in vitro in HIV and SIV infection without affecting monocyte responses to Toll-like receptor stimulation. Strikingly, in vivo treatment of SIV-infected PTMs with Ixolaris was associated with significant decreases in D-dimer and immune activation. These data suggest that TF-expressing monocytes are at the epicenter of inflammation and coagulation in chronic HIV and SIV infection and may represent a potential therapeutic target.

Indexed as

AnimalsAntibodies, ViralAnti-Retroviral AgentsBlood CoagulationBlood Coagulation DisordersChlorocebus aethiopsChronic DiseaseCytokinesHIV InfectionsHumansInflammationInflammation MediatorsLipopolysaccharide ReceptorsLipopolysaccharidesMonocytesReceptor, PAR-1Antibodies, ViralAnti-Retroviral AgentsCytokinesInflammation MediatorsLipopolysaccharide ReceptorsLipopolysaccharidesReceptor, PAR-1Thromboplastin

Identifiers

PMID28855397
PMCPMC5755598
OpenAlexW2751867946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.